BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23132697)

  • 1. Genetic and epigenetic states of the GNAS complex in pseudohypoparathyroidism type Ib using methylation-specific multiplex ligation-dependent probe amplification assay.
    Yuno A; Usui T; Yambe Y; Higashi K; Ugi S; Shinoda J; Mashio Y; Shimatsu A
    Eur J Endocrinol; 2013 Feb; 168(2):169-75. PubMed ID: 23132697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS.
    Bastepe M; Fröhlich LF; Hendy GN; Indridason OS; Josse RG; Koshiyama H; Körkkö J; Nakamoto JM; Rosenbloom AL; Slyper AH; Sugimoto T; Tsatsoulis A; Crawford JD; Jüppner H
    J Clin Invest; 2003 Oct; 112(8):1255-63. PubMed ID: 14561710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GNAS locus and pseudohypoparathyroidism.
    Bastepe M
    Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Multiple Families With Single Individuals Affected by Pseudohypoparathyroidism Type Ib (PHP1B) Reveals Only One Novel Maternally Inherited GNAS Deletion.
    Takatani R; Molinaro A; Grigelioniene G; Tafaj O; Watanabe T; Reyes M; Sharma A; Singhal V; Raymond FL; Linglart A; Jüppner H
    J Bone Miner Res; 2016 Apr; 31(4):796-805. PubMed ID: 26479409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the methylation at the GNAS locus identifies subtypes of sporadic pseudohypoparathyroidism type Ib.
    Maupetit-Méhouas S; Mariot V; Reynès C; Bertrand G; Feillet F; Carel JC; Simon D; Bihan H; Gajdos V; Devouge E; Shenoy S; Agbo-Kpati P; Ronan A; Naud-Saudreau C; Lienhardt A; Silve C; Linglart A
    J Med Genet; 2011 Jan; 48(1):55-63. PubMed ID: 20972248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characterization and identification of two novel mutations of the GNAS gene in patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism.
    Jin HY; Lee BH; Choi JH; Kim GH; Kim JK; Lee JH; Yu J; Yoo JH; Ko CW; Lim HH; Chung HR; Yoo HW
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):207-13. PubMed ID: 21521295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?
    Mantovani G; Elli FM; Spada A
    Horm Metab Res; 2012 Sep; 44(10):716-23. PubMed ID: 22674477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Gnas epigenetic changes and pseudohypoparathyroidism type Ib in mice with targeted disruption of syntaxin-16.
    Fröhlich LF; Bastepe M; Ozturk D; Abu-Zahra H; Jüppner H
    Endocrinology; 2007 Jun; 148(6):2925-35. PubMed ID: 17317779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.
    Elli FM; de Sanctis L; Bollati V; Tarantini L; Filopanti M; Barbieri AM; Peverelli E; Beck-Peccoz P; Spada A; Mantovani G
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E508-17. PubMed ID: 24423294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal-dominant pseudohypoparathyroidism type Ib is caused by different microdeletions within or upstream of the GNAS locus.
    Jüppner H; Linglart A; Fröhlich LF; Bastepe M
    Ann N Y Acad Sci; 2006 Apr; 1068():250-5. PubMed ID: 16831926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular symptoms in a patient with familial pseudohypoparathyroidism type Ib diagnosed by methylation-specific multiplex ligation-dependent probe amplification.
    Nagasaki K; Tsuchiya S; Saitoh A; Ogata T; Fukami M
    Endocr J; 2013; 60(2):231-6. PubMed ID: 23095209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
    Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide DNA methylation analysis of pseudohypoparathyroidism patients with GNAS imprinting defects.
    Rochtus A; Martin-Trujillo A; Izzi B; Elli F; Garin I; Linglart A; Mantovani G; Perez de Nanclares G; Thiele S; Decallonne B; Van Geet C; Monk D; Freson K
    Clin Epigenetics; 2016; 8():10. PubMed ID: 26819647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudohypoparathyroidism type Ib associated with novel duplications in the GNAS locus.
    Perez-Nanclares G; Velayos T; Vela A; Muñoz-Torres M; Castaño L
    PLoS One; 2015; 10(2):e0117691. PubMed ID: 25710380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS.
    Linglart A; Gensure RC; Olney RC; Jüppner H; Bastepe M
    Am J Hum Genet; 2005 May; 76(5):804-14. PubMed ID: 15800843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy.
    de Nanclares GP; Fernández-Rebollo E; Santin I; García-Cuartero B; Gaztambide S; Menéndez E; Morales MJ; Pombo M; Bilbao JR; Barros F; Zazo N; Ahrens W; Jüppner H; Hiort O; Castaño L; Bastepe M
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2370-3. PubMed ID: 17405843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus.
    Zazo C; Thiele S; Martín C; Fernandez-Rebollo E; Martinez-Indart L; Werner R; Garin I; ; Hiort O; Perez de Nanclares G
    J Bone Miner Res; 2011 Aug; 26(8):1864-70. PubMed ID: 21351142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus.
    Linglart A; Bastepe M; Jüppner H
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):822-31. PubMed ID: 17651445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different pattern of epigenetic changes of the GNAS gene locus in patients with pseudohypoparathyroidism type Ic confirm the heterogeneity of underlying pathomechanisms in this subgroup of pseudohypoparathyroidism and the demand for a new classification of GNAS-related disorders.
    Brix B; Werner R; Staedt P; Struve D; Hiort O; Thiele S
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1564-70. PubMed ID: 24878042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR-based analysis of differentially methylated regions of GNAS enables convenient diagnostic testing of pseudohypoparathyroidism type Ib.
    Weinhaeusel A; Thiele S; Hofner M; Hiort O; Noehammer C
    Clin Chem; 2008 Sep; 54(9):1537-45. PubMed ID: 18617581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.